rss
Arch Dis Child Fetal Neonatal Ed 2002;87:F106-F112 doi:10.1136/fn.87.2.F106
  • Original article

Central and autonomic system signs with in utero drug exposure

  1. H S Bada1,
  2. C R Bauer2,
  3. S Shankaran3,
  4. B Lester4,
  5. L L Wright5,
  6. A Das6,
  7. K Poole6,
  8. V L Smeriglio7,
  9. L P Finnegan8,
  10. P L Maza9
  1. 1University of Kentucky, Department of Pediatrics, Lexington, KY, USA
  2. 2University of Miami School of Medicine, Department of Pediatrics, Miami, FL, USA
  3. 3Wayne State University School of Medicine, Department of Pediatrics, Detroit, MI, USA
  4. 4Brown University School of Medicine, Department of Pediatrics, Women’s and Infants Hospital, Providence, RI, USA
  5. 5National Institute of Child Health and Human Development (NICHD), Bethesda, MD, USA
  6. 6Research Triangle Institute, Research Triangle Park, NC, USA
  7. 7National Institute on Drug Abuse (NIDA), Bethesda, MD, USA
  8. 8Office of Research on Women’s Health, National Institutes of Health, Bethesda, MD, USA
  9. 9Administration of Children, Youth and Families (ACYF), Washington, DC, USA
  1. Correspondence to:
    Dr H S Bada, 800 Rose Street, Room MS473, Kexington, KY 40536-0198, USA;
    hbada{at}uky.edu
  • Accepted 4 April 2002

Abstract

Aims: To determine risk for central nervous system/autonomic nervous system (CNS/ANS) signs following in utero cocaine and opiate exposure.

Methods: A multisite study was designed to determine outcomes of in utero cocaine and opiate exposure. A total of 11 811 maternal/infant dyads were enrolled. Drug exposed (EXP) infants were identified by maternal self report of cocaine or opiate use or by meconium testing. Of 1185 EXP, meconium analysis confirmed exposure in 717 to cocaine (CO) only, 100 to opiates (OP), and 92 to opiates plus cocaine (OP+CO); 276 had insufficient or no meconium to confirm maternal self report. Negative exposure history was confirmed in 7442 by meconium analysis and unconfirmed in 3184. Examiners masked to exposure status, assessed each enrolled infant. Using generalised estimating equations, adjusted odds ratios (OR) and 95% confidence intervals (CI) were estimated for manifesting a constellation of CNS/ANS outcomes and for each sign associated with cocaine and opiate exposure.

Results: Prevalence of CNS/ANS signs was low in CO, and highest in OP+CO. Signs were significantly related to one another. After controlling for confounders, CO was associated with increased risk of manifesting a constellation of CNS/ANS outcomes, OR (95% CI): 1.7 (1.2 to 2.2), independent of OP effect, OR (95% CI): 2.8 (2.1 to 3.7). OP+CO had additive effects, OR (95% CI): 4.8 (2.9 to 7.9). Smoking also increased the risk for the constellation of CNS/ANS signs, OR (95% CI) of 1.3 (1.04 to 1.55) and 1.4 (1.2 to 1.6), respectively, for use of less than half a pack per day and half a pack per day or more.

Conclusion: Cocaine or opiate exposure increases the risk for manifesting a constellation of CNS/ANS outcomes.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.